NDC Code(s) : 51079-351-01, 51079-351-16, 51079-352-01, 51079-352-16, 51079-353-01, 51079-353-16, 51079-354-01, 51079-354-16
Packager : Mylan Institutional Inc.
Category : HUMAN PRESCRIPTION DRUG LABEL
DEA Schedule : none
Marketing Status : New Drug Application
INGREDIENTS AND APPEARANCE
Ziprasidone Hydrochlorideziprasidone hydrochloride CAPSULE | ||||||||||||||||||||||||||
|
||||||||||||||||||||||||||
|
||||||||||||||||||||||||||
|
||||||||||||||||||||||||||
|
||||||||||||||||||||||||||
|
||||||||||||||||||||||||||
|
Ziprasidone Hydrochlorideziprasidone hydrochloride CAPSULE | ||||||||||||||||||||||||||
|
||||||||||||||||||||||||||
|
||||||||||||||||||||||||||
|
||||||||||||||||||||||||||
|
||||||||||||||||||||||||||
|
||||||||||||||||||||||||||
|
Ziprasidone Hydrochlorideziprasidone hydrochloride CAPSULE | ||||||||||||||||||||||||
|
||||||||||||||||||||||||
|
||||||||||||||||||||||||
|
||||||||||||||||||||||||
|
||||||||||||||||||||||||
|
||||||||||||||||||||||||
|
Ziprasidone Hydrochlorideziprasidone hydrochloride CAPSULE | ||||||||||||||||||||||||||
|
||||||||||||||||||||||||||
|
||||||||||||||||||||||||||
|
||||||||||||||||||||||||||
|
||||||||||||||||||||||||||
|
||||||||||||||||||||||||||
|
PRINCIPAL DISPLAY PANEL
PRINCIPAL DISPLAY PANEL - 20 mg
NDC 51079-351-16
Ziprasidone HCl
Capsules
20 mg*
60 Capsules (10 x 6)
*Each capsule contains ziprasidone
hydrochloride monohydrate, USP
equivalent to 20 mg of ziprasidone.
Usual Dosage: See accompanying
prescribing information and Patient
Information Leaflet.
Store at 20° to 25°C (68° to 77°F).
[See USP Controlled Room
Temperature.]
Code No.: MH/DRUGS/25/NKD/89
Manufactured for:
Mylan Pharmaceuticals Inc.
Morgantown, WV 26505 U.S.A.
Made in India
Rx only
S-11297
Code No.: MH/DRUGS/25/NKD/89
Packaged and Distributed by:
Mylan Institutional Inc.
Rockford, IL 61103 U.S.A.
This unit dose package is not child resistant.
For institutional use only.
Keep this and all drugs out of the reach of children.
This container provides light-resistance.
See window for lot number and expiration date.
PRINCIPAL DISPLAY PANEL
PRINCIPAL DISPLAY PANEL - 40 mg
NDC 51079-352-16
Ziprasidone HCl
Capsules
40 mg*
60 Capsules (10 x 6)
*Each capsule contains ziprasidone
hydrochloride monohydrate, USP
equivalent to 40 mg of ziprasidone.
Usual Dosage: See accompanying
prescribing information and Patient
Information Leaflet.
Store at 20° to 25°C (68° to 77°F).
[See USP Controlled Room
Temperature.]
Code No.: MH/DRUGS/25/NKD/89
Manufactured for:
Mylan Pharmaceuticals Inc.
Morgantown, WV 26505 U.S.A.
Made in India
Rx only
S-11298
Packaged and Distributed by:
Mylan Institutional Inc.
Rockford, IL 61103 U.S.A.
This unit dose package is not child resistant.
For institutional use only.
Keep this and all drugs out of the reach of children.
This container provides light-resistance.
See window for lot number and expiration date.
PRINCIPAL DISPLAY PANEL
PRINCIPAL DISPLAY PANEL - 60 mg
NDC 51079-353-16
Ziprasidone HCl
Capsules
60 mg*
60 Capsules (10 x 6)
*Each capsule contains ziprasidone
hydrochloride monohydrate, USP
equivalent to 60 mg of ziprasidone.
Usual Dosage: See accompanying
prescribing information and Patient
Information Leaflet.
Store at 20° to 25°C (68° to 77°F).
[See USP Controlled Room
Temperature.]
Code No.: MH/DRUGS/25/NKD/89
Manufactured for:
Mylan Pharmaceuticals Inc.
Morgantown, WV 26505 U.S.A.
Made in India
Rx only
S-11299
Packaged and Distributed by:
Mylan Institutional Inc.
Rockford, IL 61103 U.S.A.
This unit dose package is not child resistant.
For institutional use only.
Keep this and all drugs out of the reach of children.
This container provides light-resistance.
See window for lot number and expiration date.
PRINCIPAL DISPLAY PANEL
PRINCIPAL DISPLAY PANEL - 80 mg
NDC 51079-354-16
Ziprasidone HCl
Capsules
80 mg*
60 Capsules (10 x 6)
*Each capsule contains ziprasidone
hydrochloride monohydrate, USP
equivalent to 80 mg of ziprasidone.
Usual Dosage: See accompanying
prescribing information and Patient
Information Leaflet.
Store at 20° to 25°C (68° to 77°F).
[See USP Controlled Room
Temperature.]
Code No.: MH/DRUGS/25/NKD/89
Manufactured for:
Mylan Pharmaceuticals Inc.
Morgantown, WV 26505 U.S.A.
Made in India
Rx only
S-11300
Packaged and Distributed by:
Mylan Institutional Inc.
Rockford, IL 61103 U.S.A.
This unit dose package is not child resistant.
For institutional use only.
Keep this and all drugs out of the reach of children.
This container provides light-resistance.
See window for lot number and expiration date.